Equities
Health CareMedical Equipment and Services
  • Price (JPY)205.00
  • Today's Change4.00 / 1.99%
  • Shares traded333.50k
  • 1 Year change-26.26%
  • Beta1.2091
Data delayed at least 20 minutes, as of May 07 2024 01:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.

  • Revenue in JPY (TTM)4.13bn
  • Net income in JPY-1.32bn
  • Incorporated2004
  • Employees257.00
  • Location
    Cyberdyne Inc2-2-1, Gakuen-MinamiTSUKUBA-SHI 305-0818JapanJPN
  • Phone+81 298553189
  • Fax+81 298553181
  • Websitehttps://www.cyberdyne.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Techno Medica Co Ltd9.73bn1.23bn15.15bn225.0011.550.912311.261.56149.84149.841,190.251,896.310.58222.413.6343,247,240.007.386.598.357.6449.9248.1612.6712.035.27--0.0039.88-3.421.60-10.20-2.5418.515.92
HOSHI IRYO-SANKI CO., LTD14.59bn1.38bn16.96bn470.0011.290.94397.361.16441.64441.644,683.445,281.520.686823.495.7631,036,470.006.535.438.216.8948.6749.229.508.332.83--0.0017.697.895.7213.237.7710.738.45
Medius Holdings Co Ltd247.46bn1.14bn17.10bn2.29k14.860.90986.030.069151.9451.9411,254.21848.562.3317.024.37108,156,900.001.081.644.416.0212.1311.490.46220.58370.896268.940.589931.155.497.29-19.8015.0942.529.46
Daiken Medical Co Ltd9.65bn912.09m17.70bn188.0017.512.3115.751.8431.7531.75335.80240.850.87443.723.5951,314,050.008.277.1812.1210.4739.0542.969.459.251.52509.690.267673.266.991.25-14.32-6.79-20.77-0.9711
Seed Co Ltd32.05bn648.96m17.83bn974.0022.721.145.330.556325.9225.921,280.20514.910.7562.447.7632,903,220.001.431.572.542.7942.5542.591.892.120.613226.090.632447.176.101.91-127.39---34.239.86
Japan Medical Dynamic Marketing, INC.23.18bn1.27bn17.98bn488.0014.060.70096.200.775648.3048.30880.53968.740.76090.68154.15--4.296.514.927.5363.6966.975.638.882.11--0.055218.268.786.74-10.68-8.52-2.959.24
Japan Tissue Engineering Co., Ltd.2.51bn143.17m25.83bn215.00180.404.2593.1710.273.533.5361.91149.730.36253.534.26--2.06-4.722.37-5.3167.2457.305.69-16.385.85996.59----23.701.29119.63--30.22--
Cyberdyne Inc4.13bn-1.32bn27.63bn257.00--1.03--6.68-6.22-6.2219.52195.180.08141.949.0416,081,710.00-2.90-0.7423-2.95-0.754449.6065.33-35.62-16.4417.29--0.015--52.9813.7440.16---14.67--
Nippon Care Supply Co., Ltd.27.74bn1.50bn31.08bn1.25k19.761.844.191.1296.2596.251,785.431,032.501.20125.2123.4422,122,560.006.447.878.6910.1936.1338.345.397.350.7474--0.093653.1111.149.66-9.601.2036.008.76
Win-Partners Co Ltd74.40bn1.69bn35.57bn609.0019.591.4718.680.478159.5159.512,613.33795.081.7221.314.38122,162,200.003.934.967.139.1712.3312.502.282.981.75--0.0052.936.722.4311.76-7.3937.315.92
Rion Co Ltd25.73bn2.65bn39.08bn998.0014.711.3411.001.52215.52215.522,090.412,372.880.71771.863.46--7.406.278.627.2550.7150.2910.318.852.53----27.517.793.8647.395.7825.244.56
CI Medical Co Ltd45.63bn2.08bn40.10bn473.0019.262.0012.840.8789208.22208.224,563.262,005.931.274.2514.4796,465,120.005.8610.8310.7015.6526.2927.734.606.060.4438--0.460512.836.3812.07-17.419.3877.2413.65
Data as of May 07 2024. Currency figures normalised to Cyberdyne Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

3.52%Per cent of shares held by top holders
HolderShares% Held
Sawakami Asset Management, Inc.as of 31 Jan 20241.69m1.23%
BlackRock Fund Advisorsas of 04 Apr 20241.52m1.11%
Simplex Asset Management Co., Ltd.as of 04 Apr 2024522.40k0.38%
Dimensional Fund Advisors LPas of 04 Apr 2024437.00k0.32%
BlackRock Advisors (UK) Ltd.as of 02 Apr 2024209.50k0.15%
Global X Japan Co., Ltd.as of 05 Apr 2024121.50k0.09%
SSgA Funds Management, Inc.as of 04 Apr 202488.20k0.06%
Nikko Asset Management Co., Ltd.as of 20 Jan 202387.00k0.06%
AcomeA SGR SpAas of 30 Jun 202381.80k0.06%
TIAA-CREF Investment Management LLCas of 29 Feb 202475.53k0.06%
More ▼
Data from 02 Nov 2023 - 01 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.